Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial health with a focus on profitable growth, strategic capital deployment, and a disciplined approach to M&A. The company is leveraging its market position for favorable pricing and has plans for significant share buybacks, indicating confidence in future performance. Despite some uncertainties in reinsurance pricing, particularly in Florida, the overall sentiment is positive due to the company's strategic focus and robust capital management.
Gross Written Premiums $4.3 billion, down 8.6% year-over-year in constant dollars, primarily due to the sale of the commercial retail business and deliberate underwriting actions in U.S. casualty lines.
Net Investment Income $562 million, up significantly from the prior year, driven by growth in the fixed income portfolio and strong performance from limited partnerships.
Combined Ratio 98.4%, including $216 million of catastrophe losses and $122 million of ADC premium. Excluding these impacts, the attritional combined ratio was 89.9%, reflecting improved loss experience and focus on margin development.
Operating Return on Equity (ROE) 12.4% for the year, supported by strategic actions like the adverse development cover and portfolio reshaping.
Total Shareholder Return (TSR) 13.1% for the year, attributed to operational improvements and capital management strategies.
Net Operating Income $549 million for the quarter, reflecting contributions from underwriting and investment portfolio.
Attritional Loss Ratio 60.2% for the quarter, improved by 3.7 points year-over-year due to better loss experience and prudent loss picks in U.S. casualty lines.
Book Value Per Share $379.83 at year-end, an improvement of 20.1% from the prior year-end, adjusted for dividends.
Share Repurchases $400 million in Q4 and $800 million for the full year, reflecting a focus on capital return to shareholders.
Specialty Book Development: The specialty book has grown to approximately $2 billion in premium, with an attritional loss ratio in the mid-80s.
Global Wholesale and Specialty Platform: Gross written premium for the Global Wholesale and Specialty business was $3.6 billion at year-end 2025, including $1.2 billion in facultative business.
Asia Expansion: Attractive opportunities in Asia, including a new India branch, are being pursued.
Global Reinsurance Renewals: Bound over $6.3 billion of premium at January 1, 2026, with a slight decrease of under 1% compared to expiring premiums.
Reserve Risk Reduction: Implemented a $1.2 billion adverse development cover to reduce reserve risk.
Portfolio Reshaping: Exited the commercial retail insurance business, selling renewal rights to AIG for $426 million.
Investment Income Growth: Net investment income increased to $562 million, driven by growth in the fixed income portfolio and strong performance from limited partnerships.
Management Team Strengthening: Several new executives joined in critical roles to enhance management capabilities.
Share Repurchases: Repurchased $400 million of shares in Q4 2025 and an additional $100 million in January 2026, prioritizing share buybacks as a use of excess capital.
Market Conditions: Market conditions softened across many lines in the January 1 reinsurance renewals, with property catastrophe rates down an average of 10% globally. This could impact profitability and revenue.
Regulatory and Legal Risks: Ongoing challenges posed by the abuse of the U.S. legal system, particularly in U.S. liability lines, create an elevated risk environment and uncertainty in loss picks.
Strategic Execution Risks: The divestiture of the commercial retail insurance business to AIG creates short-term pressure on the group expense ratio and restructuring charges of approximately $150 million are expected in 2026.
Supply Chain and Operational Risks: Transitioning the commercial retail insurance portfolio to AIG involves operational complexities and potential disruptions.
Economic Uncertainties: Declining rates in property insurance, down 11%, could affect revenue and profitability despite remaining above required technical price.
Catastrophe Losses: Catastrophe losses contributed 5.6 points to the group combined ratio, driven by events like Hurricane Melissa and other midsized global events.
Investment Risks: Operating cash flow was negative $398 million in Q4, primarily due to the consideration paid for the adverse development cover, which could impact liquidity.
Competitive Pressures: Selective capacity deployment and reduced exposure to less profitable deals indicate competitive pressures in the reinsurance market.
Market Conditions and Pricing: Market conditions softened across many lines in the January 1 reinsurance renewals, with property catastrophe rates down an average of 10% globally. However, terms and conditions largely held, indicating underlying market discipline. North American casualty pricing continues to exceed average loss trends, with increases in GL, auto, and umbrella excess lines, in some cases, as much as 20%. Property rates declined by 11% but remain above required technical price.
Reinsurance Portfolio Adjustments: The company deliberately resized its casualty portfolio, reducing over $1.2 billion in premium since January 2024. Total property limit deployed decreased modestly by 2% for the first time since 2022. Capacity deployment was selective, retaining over 95% of in-force premium with top-tier accounts while reducing exposure to less profitable deals.
Growth Opportunities: Attractive opportunities are identified in Asia, including the new India branch, and in targeted specialty lines. The global development of data centers, energy capacity, and infrastructure investments is expected to propel and diversify the specialty book, which is now approximately $2 billion in premium with an attritional loss ratio in the mid-80s.
Global Wholesale and Specialty Platform: The platform is expected to generate reasonable underwriting profits with additional mix improvement anticipated to increase profitability over the course of 2026. The business is positioned to become a more significant share of Everest's earnings mix over time.
Capital Management: The company plans to prioritize share repurchases as a use of excess capital, with $400 million repurchased in Q4 2025 and an additional $100 million in January 2026. A quarterly floor of $200 million for share repurchases is set for 2026, with a willingness to exceed this amount depending on conditions.
Restructuring and Expense Management: Approximately $150 million of restructuring charges are expected throughout 2026 due to the exit from the commercial retail insurance business. This includes $80 million in real estate-related costs anticipated in Q4 2026. The company expects the other segment to run at a combined ratio above 110% in 2026, driven by higher expenses during the transition.
Reserve and Loss Picks: Elevated loss picks will be maintained in 2026 for U.S. liability lines due to environmental uncertainty. Rate increases are expected to remain in excess of loss trends for U.S. casualty lines, which will represent a smaller portion of premium writings in 2026.
Investment Income: Net investment income is expected to remain strong, supported by higher assets under management and alternative asset returns. The current new money yield is approximately 4.7%, with a short asset duration of 3.4 years and an average credit rating of AA-.
Dividend per share: $8 per share year-to-date
Share repurchase in Q4: 1.2 million shares amounting to approximately $400 million at an average share price of $320.59 per share
Share repurchase for full year 2025: 2.4 million shares amounting to approximately $800 million at an average share price of $333 per share
Share repurchase in January 2026: $100 million of common shares
Future share repurchase plan: Plan to continue share buybacks in Q1 and in 2026 as a whole, with a quarterly floor of $200 million for common share repurchases and willingness to exceed this amount, conditions permitting.
The earnings call highlights strong financial health with a focus on profitable growth, strategic capital deployment, and a disciplined approach to M&A. The company is leveraging its market position for favorable pricing and has plans for significant share buybacks, indicating confidence in future performance. Despite some uncertainties in reinsurance pricing, particularly in Florida, the overall sentiment is positive due to the company's strategic focus and robust capital management.
The earnings call reflects strong financial metrics with record investment income and strategic growth in reinsurance and specialty insurance. Despite some areas of decline, such as casualty premiums, the company is optimizing its portfolio, expecting growth in several lines, and maintaining attractive risk-adjusted returns. The Q&A indicates confidence in reserve management and strategic divestments, with plans for capital repatriation. Share repurchases and a favorable investment outlook further support a positive sentiment. However, cautious guidance and a competitive market temper expectations, suggesting moderate stock price appreciation.
The earnings call summary reveals mixed signals. The financial performance and product development updates are generally positive, with strong international growth and share repurchases. However, the combined ratio indicates ongoing pressure from losses, and there are concerns about expense ratios and the impact of tariffs. The Q&A section did not provide clear answers on critical issues, such as tariff impacts and expense improvements. The lack of clarity and mixed results suggest a neutral sentiment, with no strong catalysts for significant stock movement.
The earnings call presents mixed signals. Financial performance shows increased losses and flat premium growth, but net investment income is strong. The Q&A reveals potential growth in Florida and specialty lines, but competitive pressures and management's reluctance to provide guidance raise concerns. Share repurchases are positive, but the attritional loss ratios and catastrophe impacts are negative. Overall, the sentiment is neutral, with no strong indicators for significant stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.